EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeitOpen Access · CC BY 4.0

The Objective Response and Disease Control Rates in Patients with Liver Metastastic Breast Cancer Receiving Transarterial Radioembolization: A Meta-Analysis

Natale Quartuccio iD, Vincenzo Militano, Marco Pappalardo iD, Luca Filippi iD, Oreste Bagni, Antonino Maria Moreci, Salvatore Ialuna iD

Current Oncology · 2024

DOI: 10.3390/curroncol31110508 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Current Oncology, 2024. Verfasst von Natale Quartuccio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Unit, Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy. Hauptthemen laut MEDLINE: Liver Neoplasms, Breast Neoplasms, Embolization, Therapeutic. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To meta-analyze the utility of transarterial radioembolization (TARE) in patients with liver metastatic breast cancer (BC), based on the objective response rate (ORR) and disease control rate (DCR).

Methods

A literature search was performed retrieving studies with (1) at least 10 patients with liver metastatic BC treated with TARE and (2) adequate information to derive ORR and DCR. The ORR is the ratio between patients with liver lesions showing complete response (CR) or partial response (PR) over the total number of patients treated with TARE; the DCR is the ratio between patients with CR, PR, or stable disease (SD) over the total number of patients treated with TARE.

Results

Eighteen studies (650 patients) were eligible; the ORR of TARE resulted 50.71% (95% C.I.: 40.04–61.36) and the DCR resulted 88.37% (95% C.I.: 81.89–93.57). Taking into account resin spheres (395 patients), the ORR was 60.35% (95% C.I.: 46.55–73.36) and the DCR was 92.73% (95% C.I.: 87.17–96.80%). Considering glass spheres (144 patients), the ORR was 32.38% (95% C.I.: 18.43–48.16) and the DCR was 82.69% (95% C.I.: 59.29–97.26).

Conclusions

This meta-analysis favors the use of TARE in patients with liver metastatic BC either with resin or glass spheres.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsBreast NeoplasmsEmbolization, TherapeuticHumansFemaleTreatment OutcomeYttrium Radioisotopes

Stichwörter der Autor:innen

breast cancerdisease control rateglassobjective response rateprognosisradioembolizationresinsurvival

Substanzen

Yttrium Radioisotopes

Autor:innen und Institutionen

  • Nuclear Medicine Unit, Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy.
  • Nuclear Medicine Unit, Azienda Ospedaliera "Pugliese-Ciaccio", 88100 Catanzaro, Italy.
  • Division of Plastic Surgery, Università degli Studi di Modena e Reggio Emilia, 41121 Modena, Italy.
  • Nuclear Medicine Unit, Department of Oncohaematology, Fondazione PTV Policlinico Tor Vergata University Hospital, 00133 Roma, Italy.
  • Department of Nuclear Medicine, "Santa Maria Goretti" Hospital, 04100 Latina, Italy.

ORCID-Profile: Natale Quartuccio, Marco Pappalardo, Luca Filippi, Salvatore Ialuna

Zitieren

APA

Quartuccio, N., Militano, V., Pappalardo, M., Filippi, L., Bagni, O., Moreci, A. M., & Ialuna, S. (2024). The Objective Response and Disease Control Rates in Patients with Liver Metastastic Breast Cancer Receiving Transarterial Radioembolization: A Meta-Analysis. Current Oncology. https://doi.org/10.3390/curroncol31110508

Vancouver

Quartuccio N, Militano V, Pappalardo M, Filippi L, Bagni O, Moreci AM, et al. The Objective Response and Disease Control Rates in Patients with Liver Metastastic Breast Cancer Receiving Transarterial Radioembolization: A Meta-Analysis. Current Oncology. 2024. doi:10.3390/curroncol31110508

BibTeX
@article{Quartuccio2024,
  author = {Quartuccio, Natale and Militano, Vincenzo and Pappalardo, Marco and Filippi, Luca and Bagni, Oreste and Moreci, Antonino Maria and Ialuna, Salvatore},
  title = {The Objective Response and Disease Control Rates in Patients with Liver Metastastic Breast Cancer Receiving Transarterial Radioembolization: A Meta-Analysis},
  journal = {Current Oncology},
  year = {2024},
  doi = {10.3390/curroncol31110508}
}
Kostenlos starten →